TransMedics Group, Inc.

US$88.24As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TMDXHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR 17.14%
Div yield —
ROE 31.89%
Medical Devices
Beta (5Y) 2.10
PE TTM 22.77
TSR TTM (32.92%)
Mkt cap US$3.065B
ROIC 9.41%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$94
6.48%
(89.75%)
Hold 6|10|9|9|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.07
1.05
1.14
1.25
5.04%
(2.72%)
9.58%
22.56%
Revenue$M
178.6
186.0
194.8
202.2
12.27%
11.22%
13.05%
14.74%
Peers (US$3.065B)
Cap (US$)
PE
2.988B
—
2.567B
—
Capital
TTM
5Y
10Y
Leveragex
1.010
—
—
EBIT/Intx
0.847
1.389
1.303
Own earn%
14.29
22.92
28.63
Sh yield%
32.80
33.40
34.96
Owners
Insiders/Inst%
1.64
49.12
Short interest%
5.23
SBC / revenue%
4.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
3–8
$1 testx
—
Incr. ROIC%
12